AMGEN INC is 10.1x more valuable than Moderna, Inc. by market capitalization ($183.41 B vs $18.25 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | AMGN | MRNA |
|---|---|---|
| Market cap | $183.41 B | $18.25 B |
| US-listed rank | #79 | #650 |
| Revenue (latest FY) | $36.75B | $1.94B |
| Net income (latest FY) | $7.71B | -$2.82B |
| Net margin | 21.0% | -145.2% |
| P/E (trailing FY) | 23.8 | - |
| SEC filings | 1,011 | 1,447 |
AMGEN INC is 10.1x more valuable than Moderna, Inc. by market capitalization ($183.41 B vs $18.25 B).
In their latest fiscal years, AMGEN INC reported $36.75B in revenue while Moderna, Inc. reported $1.94B.
Full pages: AMGEN INC and Moderna, Inc., or browse the full rankings.